Advertisement

Topics

Lockton Market Update Company Profile

01:08 EST 20th November 2017 | BioPortfolio

Editors, features editors and reporters are invited to quote selections from these reports and articles to enhance their own reporting. Please contact the Lockton media team for permission to reproduce an article in its entirety or to speak with a Lockton expert. Lockton retains the rights to this copyrighted work.


News Articles [255 Associated News Articles listed on BioPortfolio]

Lockton Adds Chief Medical Officer

KANSAS CITY, Mo., Sept. 27, 2017 /PRNewswire/ -- Shealynn Buck, MD, a leading expert in employee wellbeing and improving health outcomes, has joined Lockton Benefit Group in Dallas as Chief ...

Healthcare & HR Expert Joins Lockton in Kansas City to Guide Clients

KANSAS CITY, Mo., Sept. 25, 2017 /PRNewswire/ -- Rosanna Milley understands an employer's dilemma when confronted with human resource and risk management challenges. As a new employee benefits Pr...

Update: After 25 years, MorphoSys Gets its First Antibody Approved

Update (19/09/2017): Janssen has received a positive CHMP opinion recommending the approval of Tremfya (guselkumab) in Europe for moderate to severe plaque psoriasis. The approval could make Tremfya t...

Valeant Stock Needs to Clear One More Hurdle

VRX Stock: One Piece Away from a Bull Market A number of bullish events have transpired since my last update on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock. In that May 17, 2017 update, title.....

UPDATE: AstraZeneca’s Checkpoint Inhibitor Could be a Lung Cancer Blockbuster

UPDATE: 11/09/2017: AstraZeneca has presented impressive results at ESMO that show Imfinzi adding 11 months to patient survival, or decreasing the risk of progression by 48%, in Stage 3 NSCLC. This in...

Update: The First Drug for This Rare Kidney Disease May Come From a French Biotech

Update (6/11/2017): ADV7103 has maintained its efficacy during a 6-month extension of the Phase III study, further supporting its push to become the first treatment for the disease on the market. Ori...

Update: French Red Blood Cell Biotech Aims Higher for $125M Nasdaq IPO

Update: Erytech has upgraded its projected IPO to $125M by offering more shares than originally planned. Originally published 09/10/2017 Erytech has filed for an IPO on the Nasdaq Global Market and a ...

Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug

Update (10/10/2017): Faron Pharmaceuticals’ fundraising has been oversubscribed, which reflects the excitement around its drug candidate, Traumakine. By securing £10M, Faron matches its IPO ...

Drugs and Medications [19 Associated Drugs and Medications listed on BioPortfolio]

Dandruff [Market Basket]

Drug Facts

De-aging sunscreen spf 55 [Market America]

De-Aging Sunscreen SPF 55

De-aging moisturizing day creme with sunscreen spf 20 [Market America]

De-Aging Moisturizing Day Creme With Sunscreen SPF 20

Laura lynn extra whitening sensitive [Ingles Market Inc]

Laura Lynn Extra Whitening for Sensitive Teeth

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

PubMed Articles [680 Associated PubMed Articles listed on BioPortfolio]

Association of Hospital Market Concentration With Costs of Complex Hepatopancreaticobiliary Surgery.

Trade-offs involved with market competition, overall costs to payers and consumers, and quality of care have not been well defined. Less competition within any given market may enable provider-driven ...

The Collapse of the Price of Oil and the Importance of Fair Market Competition and Optimizing Public and Private Resources: Assessing Angola's Contraceptive Market Landscape.

Stock Market Fluctuations and Self-Harm among Children and Adolescents in Hong Kong.

Although a few studies investigated the impact of stock market fluctuations on population health, the question of whether stock market fluctuations have an impact on self-harm in children and adolesce...

The Affordable Care Act's insurance market regulations' effect on coverage.

Much of the debate surrounding reform of the Patient Protection and Affordable Care Act (ACA) revolves around its insurance market regulation. This paper studies the impact on health insurance coverag...

Update on tauopathies.

The purpose of this review is to provide an update on the role of tau beyond the stabilization of microtubules and on the clinical, pathological, diagnostic and therapeutic aspects of tauopathies.

Clinical Trials [458 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Observational, Non-Interventional, Prospective, Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device

This study is designed to generate a comprehensive survey of the use on the market of the Anecova device within its intended indications according to the Instructions For Use. The Anecova ...

Post-market Surveillance Study of FLXfit™ TLIF Interbody Fusion Device

This study is a post-market clinical follow-up study. A post-market, prospective clinical trial will be conducted. The data collected from this study will serve the purpose of confirming s...

Support Annual Strain Update, Safey and Immnogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

This phase II, open label, is designed as a seasonal study to support annual strain update evaluating the safety, clinical tolerability and immunogenicity of the 2007-2008 formulation of ...

Zenith® TXD Post-market Surveillance in Japan

The study is a post-market surveillance study required by Japanese Regulatory Authorities as a condition of approval

Companies [653 Associated Companies listed on BioPortfolio]

Lockton Market Update

Editors, features editors and reporters are invited to quote selections from these reports and articles to enhance their own reporting. Please contact the Lockton media team for permission to reprodu...

Lockton Insurance Brokers, LLC

Lockton Insurance Brokers, LLC is the Southern California subsidiary of Lockton Companies, the largest independent, privately owned, global insurance broker and benefits consultan...

Lockton Benefit Group

More than 3,800 professionals at Lockton provide more than 15,000 clients around the world with insurance, benefits, surety and risk management services, offering an uncommon level of client service. ...

Lockton Companies, LLC

In 1974, Thomas Dunning founded Dunning Insurance. What was then a small insurance agency grew into a large group employee benefits brokerage and consulting practice under the name Dunning Benefits Co...

update CRM Inc.

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the U...

More Information about "Lockton Market Update" on BioPortfolio

We have published hundreds of Lockton Market Update news stories on BioPortfolio along with dozens of Lockton Market Update Clinical Trials and PubMed Articles about Lockton Market Update for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lockton Market Update Companies in our database. You can also find out about relevant Lockton Market Update Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record